City
Epaper

Researchers develop fast, accurate, low-cost Covid-19 test

By IANS | Updated: August 29, 2020 18:04 IST

Beijing, Aug 29 Chinese researchers have developed a new low-cost diagnostic test for Covid-19 which quickly delivers accurate ...

Open in App

Beijing, Aug 29 Chinese researchers have developed a new low-cost diagnostic test for Covid-19 which quickly delivers accurate results without the need for sophisticated equipment.

"In this study, we developed an isothermal, CRISPR-based diagnostic for Covid-19 with near single-copy sensitivity," the study authors from Xuzhou Medical University in China, wrote in a paper published in the journal PLOS Pathogens.

"We demonstrated a CRISPR-based assay for Covid-19 that offered shorter turn-around time and great diagnostic value, even in under-resourced settings without the need for thermal cyclers," they added.

The surging demand for rapid screening and identification of Covid-19 poses great diagnostic challenges.

Metagenomic next-generation sequencing (mNGS) and reverse-transcription PCR (RT-PCR) have been the most commonly used molecular methods for diagnosing Covid-19, but each has its own limitations.

For example, sequencing is costly and has a turnaround time of nearly one day, while RT-PCR requires specialized equipment and is difficult to deploy at a large scale.

According to the researchers, a lack of rapid and accurate molecular diagnostic tools has hampered efficient public health responses to the viral threat.

In the new study, the researchers developed an alternative Covid-19 test by leveraging CRISPR-based technology, which has been widely used in recent years for gene editing.

The assay, named CRISPR-COVID, enables high-throughput detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the virus that causes Covid-19.

CRISPR-COVID delivers comparable sensitivity and specificity as mNGS within as short as 40 minutes, the researchers said.

When produced at a large scale, the material cost of a CRISPR-COVID test could be less than 70 cents, suggesting that CRISPR-COVID is a competitive alternative not only technologically but also financially, the team noted.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Xuzhou Medical UniversityPlos pathogenschinabeijing
Open in App

Related Stories

International'Illegal Military Operations': China Accuses US and Israel of Strait of Hormuz Crisis

NationalDelhi Government Orders Removal of 2.5 Lakh Chinese CCTV Cameras Over Security Concerns

InternationalChina: Four Dead, Nine Injured After Explosion at Highway Tunnel Construction Site in Chongqing

InternationalChina: Casualties Feared After Bulldozer Runs Over Crowd in Beijing Market (Watch Video)

MumbaiMumbai: DRI Seizes Restricted Goods Worth ₹9.25 Crore; Two Firm Owners Arrested

Health Realted Stories

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns

HealthIndia’s millet push receives dual boost at technology and grassroots levels

HealthUK heart rhythm expert now performing procedures in India

HealthCoffee Scrub for Tan Removal: Try This Easy Homemade Remedy for Instant Glow

HealthJan Vishwas Bill’s provisions promise big boost to health sector: Ministry​